|
Point-of-care genetic testing incorporates the newest most sophisticated techniques to identify variations in the genetic sequence at the bedside – enabling clinicians to react and alter therapy based upon the results. Traditional genetic testing involves the analysis of DNA in order to detect genotypes related to a heritable disease or phenotype of interest for clinical purposes. However, current testing methods require days to weeks before results are available limiting the clinical applicability of genetic testing in a number of circumstances. Recently, the first point-of-care genetic test in medicine was demonstrated to be effective in identifying CYP2C19 *2 carriers allowing tailoring of anti-platelet regimens to reduce high on treatment platelet reactivity.〔http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960161-5/abstract#〕 In the RAPID GENE study,〔http://clinicaltrials.gov/ct2/show/NCT01184300〕 Drs. Jason Roberts and Derek So from the University of Ottawa Heart Institute validated a pharmacogenomics approach in patients undergoing percutaneous coronary intervention for acute coronary syndrome or stable coronary artery disease.〔http://www.winnipegfreepress.com/arts-and-life/life/health/first-bedside-gene-test-shows-promise-144912695.html〕〔http://www.theglobeandmail.com/life/health/new-health/conditions/heart-and-stroke/treatment/new-bedside-genetic-tests-pick-the-right-drug-right-away/article2393347/〕〔http://blogs.theheart.org/topolog/2012/4/11/taking-pointofcare-genetic-testing-closer-to-mainstream?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Topolog+%28Topolog%29〕 This study is the first in medicine to incorporate point-of-care testing with genetics into routine clinical care and decision making.〔http://clinicaltrialresults.org/Slides/TCT%202011/So%20Late%20breaking%20Trial%20RAPID%20GENE%20TCT%20web%20site%20version.pdf〕 ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Point-of-care genetic testing」の詳細全文を読む スポンサード リンク
|